Ministers move to clarify drug regulation Post-Brexit

04:11 EDT 4 Jul 2017 | Pharmafile

Jeremy Hunt, Health Secretary, and Greg Clark, Business Secretary, have made a bold move to suggest that the UK will look to collaborate closely with the EU to navigate drug approvals post-Brexit. The pharmaceutical industry has been pressing since the referendum for a clearer indication of the future of drug regulation in light of the Brexit decision and welcomed the move to indicate a future direction in negotiations.

read more

Original Article: Ministers move to clarify drug regulation Post-Brexit


More From BioPortfolio on "Ministers move to clarify drug regulation Post-Brexit"

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...